Claude A A Hariton

Title: **Claude A A Hariton: Innovator in Photodynamic Therapy**

Introduction

Claude A A Hariton is an accomplished inventor based in Quebec, Canada. With a total of two patents to his name, Hariton is making significant strides in the field of medical technology. His work primarily focuses on methods and compositions aimed at reducing or preventing inflammation-related complications in patients.

Latest Patents

Hariton's latest innovations include the pioneering work on photodynamic therapy for the prevention of secondary cataracts. This method utilizes photosensitizers, particularly green porphyrins, as photoactive agents. These agents effectively target and destroy remnant lens epithelial cells, significantly contributing to improved patient outcomes in cataract surgeries.

Career Highlights

Hariton's career is marked by his dedication to advancing medical therapies through innovative approaches. His two patents reflect his commitment to enhancing the efficacy of treatments, particularly in ophthalmology. His expertise and unique contributions make him a notable figure in the world of medical inventions.

Collaborations

Throughout his career, Hariton has collaborated with talented professionals, including Anna M Richter and Julia G Levy. Together, they have explored various facets of photodynamic therapy and its applications, culminating in their joint efforts to push the boundaries of medical technology.

Conclusion

Claude A A Hariton is a notable innovator whose work is reshaping treatment protocols for inflammation-related issues, particularly in the context of eye health. His patents in photodynamic therapy showcase the potential of innovative methods to enhance patient care. As he continues to collaborate with skilled associates, the future of his contributions to medical technology is indeed promising.